#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic neuroendocrine tumour Sarcoma Hydrocephalus Hyperphagia Congenital absence of bile ducts Pleomorphic leiomyosarcoma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Cystic fibrosis Neuroendocrine cell hyperplasia of infancy Uveitis Mitochondrial myopathy Ductal adenocarcinoma of pancreas Congenital hypotransferrinaemia Retinitis pigmentosa Medulloblastoma recurrent More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Life with Disease Brain stem glioma – Diagnostics Marginal zone lymphoma – Diagnostics Piriformis syndrome – Life with Disease Pelizaeus-Merzbacher disease – Diagnostics Medulloblastoma – Trials in Disease Mastocytosis – Diagnostics Leiomyosarcoma metastatic – Diagnostics Soft tissue sarcoma Krabbe’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dcc-3116 Losmapimod Montelukast Streptococcus Pneumoniae Csm-Gw Chlorpromazine Metoprolol Tartrate Isoleucine Amoxicillin Trihydrate HRS 9531 L-Tryptophan Rbl016.2 Sunvozertinib Cimetidine Mesenchymal Cells Sodium Lactate Solution Histamine Dihydrochloride Cisatracurium Besilate JX10 Regadenoson More therapies…

    Learn about Your Condition

    Hyponatraemia Metastatic gastric cancer Acquired ATTR amyloidosis Alveolar rhabdomyosarcoma Death neonatal Vertigo Metastases to rectum Arteriovenous graft thrombosis Pigmentary glaucoma Hepatitis B Post procedural complication Torticollis Embolism venous Basal cell naevus syndrome Thrombotic microangiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Regional Du Cancer De Montpellier

Institut Regional Du Cancer De Montpellier

208 Avenue Des Apothicaires, Montpellier, 34298, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Apalutamide with Radiotherapy and Hormone Therapy for High-Risk Prostate Cancer Patients with Rising PSA After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Apalutamide
    France

  • Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Capivasertib
    • Docetaxel
    Belgium Czechia France Greece Hungary The Netherlands +2

  • Study Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Albumin Solution
    • Indocyanine Green
    France

  • Study on Zoledronic Acid for Treating Osteosarcoma in Children, Adolescents, and Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zoledronic Acid Monohydrate
    France

  • Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma recurrent
    • Endometrial cancer recurrent
    • Fallopian tube cancer
    Investigated Drugs:
    • Brimonidine Tartrate
    • Imgn151
    • Prednisolone Acetate
    Belgium France Germany Ireland Italy The Netherlands +1

  • Study of ELVN-002 with Trastuzumab and Chemotherapy for Patients with Advanced HER2+ Solid Tumors, Colorectal Cancer, and Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    • HER2 positive breast cancer
    • Neoplasm
    Investigated Drugs:
    • Elvn-002-1
    • Eribulin
    • Folinic Acid
    Belgium France Italy The Netherlands Spain

  • Study on Durvalumab and Radiation Therapy for Patients with Recurrent Glioblastoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Durvalumab
    France

  • Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Breast cancer male
    • Breast cancer recurrent
    Investigated Drugs:
    • Capecitabine
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Ireland Spain

  • Study on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal mesothelioma malignant
    • Pleural mesothelioma malignant
    Investigated Drugs:
    • Talazoparib
    France

  • Study of hyperthermic intraperitoneal chemotherapy with oxaliplatin, fluorouracil, and calcium levofolinate in patients with advanced gastric cancer after surgery

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Oxaliplatin
    France
Previous Page
1 … 12 13 14 15 16 … 25
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!